Category: Forbes

Mobile App Will Transform Data Entry And Collection In Clinical Studies, Company Says

“The future of this software is that it will march in step with the future of healthcare, especially digital health, digital medicines and the smart x of everything,” said Bryan Silverman, CEO of ObvioHealth.

Stryker Beats Earnings Estimates, Barely Beats Revenue Estimates

Stryker’s shares were down about 2.5% in after hours trading following the release of its second quarter earnings Tuesday.

Warning: Pirate Sites Are Now Trying To Dupe Doctors Booking Hotels At Medical Meetings

Pirates websites are are trying to fool doctors seeking to register or book a hotel for a major medical meeting.

Pfizer CEO: How The Biopharmaceutical Industry Creates Value (And Jobs) For The U.S. Economy

The most fundamental way in which the industry creates value is by discovering and manufacturing innovative medicines that help people live longer, healthier, more productive lives.

Month Seven Of My DNA Diet Challenge: Blood, Biome and Sugar Update

Sometimes dieting based on your DNA is hard.

Glaxo’s New Research Chief Loves Big Pharma. Now He Has To Fix It

GlaxoSmithCline is turning to a new chief scientific officer, Hal Barron, to reinvigorate its drug pipeline.

Eli Lilly Beats Earnings, Plans Animal Health IPO

Eli Lilly announced it plans to file an initial public offering for its multi-billion dollar sales animal health business, Elanco. Shares of the Indianapolis-based company were up 3.5% following the news released before its second quarter earnings call…

Centene’s Obamacare Profits Surge As Insurer Enters New Markets

Centene’s second-quarter profits surged 18% thanks to improving sales and profits in the Obamacare business under the Affordable Care Act.

When Sharks Attack Lung Disease — And More Science You Won’t Learn On ‘Shark Week’

While the Discovery Channel frightens viewers during the 30th year of Shark Week, scientists are embracing the creatures for their potential to inspire life-saving therapies.

Could Viruses Attacking The Microbiome Be Responsible For Inflammatory Bowel Disease?

Researchers have discovered a correlation between viruses and inflammation in a mouse model of inflammatory bowel disease.